Recent Achievements

Research

 >>Research overview
 
 >>Research Areas
 
 >>Recent Achievements
 
 >>Research platforms
 
 >>Facilities
 
 >>Exchange & Collaboration

Recent Achievements

Recent progress of Professor Wei Lu’s research group in the field of intraoperative image-guided photothermal removal of small tumors

2019/05/18

Recently, Professor Wei Lu of the School of Pharmacy, Fudan University and Professor Zeyu Xiao of the School of Medicine, Shanghai Jiaotong University reported a new theranostic preparation of albumin-bound near-infrared II small molecule. By means of intraoperative near-infrared fluorescence imagin...

Read More
A novel biomimetic nanomedicine for effective antiglioma therapy

2019/05/17

Teams from Fudan University (Prof. Weiyue Lu’s lab) and University of California, San Diego (Prof. Liangfang Zhang’s lab) worked together to develop an active-targeting biomimetic nanomedicine based on red blood cell (RBC) membrane coating-drug nanocrystal (NC) for antiglioma therapy.

Read More
A dual-bioresponsive drug delivery depot for combination of epigenetic modulation and immune checkpoint blockade

2019/04/25

Epigenetic alteration like DNA hypermethylation plays a pivotal role in immune evasion of cancer cells during tumorigenesis. It is a common feature of heterogeneous cancer phenotypes for the reason that the tumor-associated antigen (TAA) promoter regions are hypermethylated in cancers, which lead to...

Read More
Professor Chen Jiang’s group developed a novel strategy for neurodegenerative disease treatment

2019/03/24

Recently, Professor Chen Jiang’s group from Fudan University School of Pharmacy developed a polymeric micelle drug delivery system with novel functions in modulating brain disease microenvironment and investigated its efficacy in treating Alzheimer’s disease (AD). The study was published on Advanc...

Read More
Professor Chen Jiang’s group made great progress in cancer immunotherapy

2019/03/23

Recently, Professor Chen Jiang’s group from Fudan University School of Pharmacy developed a new type of prodrug-loaded ferric oxide nanoparticles, and relevant anti-tumor immunotherapy as well as microenvironment-responsive tumor MR imaging. The relevant studies were published online in Advanced Sc...

Read More
Professor Chen Jiang’s group of Fudan University made new progress in targeted drug delivery and treatment of primary and metastatic TNBC

2019/03/23

Triple-negative breast cancer (TNBC) is an extremely hard-to-treat subtype (~15%) of breast cancer. As TNBC lacks expression of human epidermal growth factor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR), traditional small-molecule inhibitors of therapeutic targets have little/no ...

Read More
A breakthrough in bortezomib-nanomedicine

2019/03/16

Recently, the research about a novel smart anti-tumor nanomedicine was published online in Advanced Functional Materials. The work was led by Prof. Weiyue Lu of School of Pharmacy of Fudan University in partnership with Prof. Hao Wang of National Pharmaceutical Engineering Research Center. In this w...

Read More
Professor Chen Jiang's group of Fudan University made new progress in targeted drug delivery and treatment of primary and metastatic TNBC

2019/02/01

Triple-negative breast cancer (TNBC) is an extremely hard-to-treat subtype (~15%) of breast cancer. As TNBC lacks expression of human epidermal growth factor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR), traditional small-molecule inhibitors of therapeutic targets have little/no ...

Read More
Professor Jianxin Wang and associate Professor Zhiqing Pang have made important progress in targeting treatment of arthritis.

2018/12/06

On December 6, 2018, Professor Jianxin Wang and Associate Professor Zhiqing Pang from Department of Pharmaceutics, School of Pharmacy, Fudan University jointly published a research paper entitled "Route to Rheumatoid Arthritis by Macrophage-Microvesicle-Coated Nanoparticles" in Nano Letters (IF=12.0...

Read More
Teachers and students of our school returned with fruitful achievement from the 2018 China Pharmaceutical Conference

2018/12/03

On December 1, 2018, the 12th China Pharmaceutical Conference was successfully held in Guangzhou. The conference was sponsored by the Chinese Pharmaceutical Association (CPA), the Pharmaceutics Professional Committee of CPA, the China Chapter of the Controlled Release Society (CRS) and the School of...

Read More
Progress of a novel highly selective human SMS2 inhibitors that improve chronic inflammation and liver lipid metabolism

2018/10/30

Sphingomyelin (SM) is the main component of phospholipids, which serve as central regulators in various physiological pathways such as cell proliferation, cell death and apoptosis, and intracellular trafficking. SM distributes mainly in the membrane and is synthesized by sphingomyelin synthase 1/2 (...

Read More
The innovative anti-hyperlipidemia drug has received clinical trial approval

2018/06/29

Recently, news released from the State Drug Administration (SFDA) that the innovative small molecule drug with new mechanism, leonurine sulfate tablets (referred to as “SCM-198”) which was previously transferred to Zhongzhu Medical, has been approved by the SFDA for clinical trial. The Approval (N...

Read More
A novel clinical pharmacy talent management model has won Fudan and Shanghai teaching and learning awards

2018/05/15

Recently, winners of the ‘2017 Fudan University Teaching and Learning Awards’were announced. The Innovations in Talent Management Model in Clinical Pharmacy finished by School of Pharmacy was awarded the first prize (participants included HOU Aijun, CAI Weimin, MA Guo, LV Qianzhou, ZHONG Mingkang,...

Read More
Important progress in the field of iron homeostasis has been made by Qian's group

2017/12/26

Cystathionine b-synthase (CBS) deficiency results in homocysteinuria, a rare genetic disorder characterized by a constellation of symptoms ranging from developmental delay to thromboembolism and megaloblastic anemia. Given that products of CBS metabolism interact with interlukin-6 (IL-6), a major de...

Read More
The research achievement of our school “Research on brain tumor-targeted drug delivery” won the second prize of Shanghai Natural Science Award (2016) and the second prize of excellent achievements in Scientific Research in Universities (2016)

2017/03/27

The scientific research achievement of our School, “Research on brain tumor-targeted drug delivery”, won the Second Prize of Shanghai Natural Science Award (2016) and the Second Prize of Excellent Achievements in Scientific Research in Universities (2016). This achievement was accomplished by Prof...

Read More
A successful transfer of leonurine with 150 million RMB from School of Pharmacy of Fudan University research project

2016/12/06

After over 10 years of hard working, the research team led by Prof. Yizhun Zhu from School of Pharmacy of Fudan University has extracted leonurine (also known as SCM-198) from the Chinese herbal medicine Motherwort with obvious curative effect on stroke.

Read More
Three achievements of department of pharmaceutics won prizes in the 1st competition of achievements in industry, research, education and medicine for health and nanotechnology

2015/12/14

The 1st Competition of Achievements in Industry, Research, Education and Medicine for Health and Nanotechnology was held on Dec 9, 2016 in Shanghai. More than 170 projects participated in this competition. Professor Weiyue Lu of Department of Pharmaceutics was invited to give a speech in the summit ...

Read More
The researches led by Associate Professor Wei Gang have aroused wide public concern

2015/09/01

With rapid population aging and the prevalence of electronics, diseases in fundus oculi, such as age-related macular degeneration and proliferative diabetic retinopathy, have been the leading cause of blindness worldwide. For example, age-related macular degeneration incidence is about 8% in people ...

Read More

firstpage <<previouspage nextpage>> endpage
PageNumber 5/5

杏悦专业提供：杏悦、、等服务，提供最新官网平台、地址、注册、登陆、登录、入口、全站、网站、网页、网址、娱乐、手机版、app、下载、欧洲杯、欧冠、nba、世界杯、英超等，界面美观优质完美，安全稳定，服务一流🍘，杏悦欢迎您。杏悦官网xml地图

Recent progress of Professor Wei Lu’s research group in the field of intraoperative image-guided photothermal removal of small tumors

A novel biomimetic nanomedicine for effective antiglioma therapy

A dual-bioresponsive drug delivery depot for combination of epigenetic modulation and immune checkpoint blockade

Professor Chen Jiang’s group developed a novel strategy for neurodegenerative disease treatment

Professor Chen Jiang’s group made great progress in cancer immunotherapy

Professor Chen Jiang’s group of Fudan University made new progress in targeted drug delivery and treatment of primary and metastatic TNBC

A breakthrough in bortezomib-nanomedicine

Professor Chen Jiang's group of Fudan University made new progress in targeted drug delivery and treatment of primary and metastatic TNBC

Professor Jianxin Wang and associate Professor Zhiqing Pang have made important progress in targeting treatment of arthritis.

Teachers and students of our school returned with fruitful achievement from the 2018 China Pharmaceutical Conference

Progress of a novel highly selective human SMS2 inhibitors that improve chronic inflammation and liver lipid metabolism

The innovative anti-hyperlipidemia drug has received clinical trial approval

A novel clinical pharmacy talent management model has won Fudan and Shanghai teaching and learning awards

Important progress in the field of iron homeostasis has been made by Qian's group

The research achievement of our school “Research on brain tumor-targeted drug delivery” won the second prize of Shanghai Natural Science Award (2016) and the second prize of excellent achievements in Scientific Research in Universities (2016)

A successful transfer of leonurine with 150 million RMB from School of Pharmacy of Fudan University research project

Three achievements of department of pharmaceutics won prizes in the 1st competition of achievements in industry, research, education and medicine for health and nanotechnology

The researches led by Associate Professor Wei Gang have aroused wide public concern